In an 8-K filing this afternoon, recent momentum over Repros Therapeutics Inc. (Nasdaq: RPRX) disclsoed that the company has decided ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE